Patrick Horber, M.D.

As President of the International unit for Novartis, Dr. Patrick Horber focuses on strengthening and growing the company’s business in Europe, Asia, Africa, Australasia, Canada and Latin America. 

Patrick has more than 20 years of experience in the biopharma sector. A proven leader with a deep understanding of the global pharmaceutical market, Patrick has significant experience enabling commercial performance on a global scale. 

It’s a great privilege and responsibility to bring the next generation of transformative medicines to patients worldwide. In my childhood, I was fascinated early on by the power of medicine and chose a career in healthcare to help patients and society. As a medical doctor, I’m proud of the groundbreaking work we do at Novartis. I’m committed to using my scientific, commercial, and leadership experience to expand and accelerate access, partnering with healthcare systems to remove barriers and unlock the full potential of our medicines for patients and society.

Patrick joined Novartis from AbbVie, where he served as senior vice president AbbVie and president, Immunology. He was responsible for their Immunology Business Unit, leading the global strategy including global commercial development and the US execution. Prior to this role, as president, US Commercial Operations, Immunology, he successfully led the launch of two major immunology medicines in multiple indications in the US market and held a variety of leadership and general management positions in the US and in Europe. 

Before joining AbbVie, Patrick held positions of increasing responsibility at Roche across diverse therapeutic areas including oncology, hematology, cardiometabolism, virology and anemia. He began his career in the healthcare practice of A.T. Kearney International.

Patrick holds a doctor of medicine from the University of Zurich in his native Switzerland. He speaks five languages. 

Outside of Novartis, Patrick enjoys diving, running, and spending time travelling with his wife and son.